pharma manufacturing

Pharma Exporters Face Soaring Costs & Supply Chain Woes A modern pharmaceutical factory at dusk with shipping containers full of medical products and an overlay of rising financial graphs.

A modern pharmaceutical factory at dusk with shipping containers full of medical products and an overlay of rising financial graphs.

Pharma Exporters Face Soaring Costs & Supply Chain Woes

sivam March 9, 2026

Indian pharma exporters struggle with rising freight costs and supply chain disruptions due to West Asia tensions....

Cipla USA Recalls Nilotinib Anti-Cancer Drug Due to Defect A gloved hand holds a vial of Nilotinib, with a pharmaceutical manufacturing facility in the background.

A gloved hand holds a vial of Nilotinib, with a pharmaceutical manufacturing facility in the background.

Cipla USA Recalls Nilotinib Anti-Cancer Drug Due to Defect

sivam March 8, 2026

Cipla USA recalls Nilotinib anti-cancer capsules (150mg and 200mg) due to a manufacturing defect, as confirmed by...

Semaglutide vs. Tirzepatide: Novo Nordisk Gains in India A scientific image depicting Semaglutide, Novo Nordisk, Eli Lilly, and an upward arrow indicating market competition in India.

A scientific image depicting Semaglutide, Novo Nordisk, Eli Lilly, and an upward arrow indicating market competition in India.

Semaglutide vs. Tirzepatide: Novo Nordisk Gains in India

sivam March 8, 2026

Novo Nordisk's semaglutide is rapidly gaining ground in India's anti-obesity market, challenging Eli Lilly's tirzepatide. Discover how...

India to Lead Global Homoeopathy Market with Quality Certifications India map with glowing nodes, global map, pharmaceutical equipment, and quality certification logos (GMP, ISO 9001, AYUSH Premium).

India map with glowing nodes, global map, pharmaceutical equipment, and quality certification logos (GMP, ISO 9001, AYUSH Premium).

India to Lead Global Homoeopathy Market with Quality Certifications

sivam March 8, 2026

India is set to dominate the global homoeopathy market, driven by clinical expertise, strong practitioner networks, and...

Cipla Recalls Cancer Drug in US Due to Manufacturing Flaw Two scientists in a sterile lab, with a "RECALL" box in the foreground and a robot arm spilling pills.

Two scientists in a sterile lab, with a "RECALL" box in the foreground and a robot arm spilling pills.

Cipla Recalls Cancer Drug in US Due to Manufacturing Flaw

sivam March 8, 2026

Cipla USA recalls Nilotinib Capsules, a cancer drug, due to a manufacturing issue. The Class III recall...

West Asia Conflict: Jets, Shipping & Drug Price Surge A composite image depicting a fighter jet, a cargo ship on a map, and a chart showing rising drug prices.

A composite image depicting a fighter jet, a cargo ship on a map, and a chart showing rising drug prices.

West Asia Conflict: Jets, Shipping & Drug Price Surge

sivam March 6, 2026

The West Asia conflict fuels economic shifts: soaring private jet demand, potential shipping disruptions, and rising drug...

Iran Conflict Disrupts India’s Pharma Exports, $500M at Risk A large pill with the Indian flag, an arrow indicating a $500M loss, and a storm below a cracked road.

A large pill with the Indian flag, an arrow indicating a $500M loss, and a storm below a cracked road.

Iran Conflict Disrupts India’s Pharma Exports, $500M at Risk

sivam March 5, 2026

The Iran conflict threatens India's pharmaceutical exports, potentially costing $500 million. Increased freight costs and shipping disruptions...

India Pharma Exports at Risk: Middle East Conflict Impact A map of the Middle East and surrounding regions with a downward trending graph, illustrating the impact on pharma exports.

A map of the Middle East and surrounding regions with a downward trending graph, illustrating the impact on pharma exports.

India Pharma Exports at Risk: Middle East Conflict Impact

sivam March 5, 2026

Escalating Middle East conflict threatens India's pharma exports. Expect shipping delays, higher costs, and supply chain disruptions...

Glenmark’s Fluticasone Inhaler Approved by US FDA A modern fluticasone inhaler with Glenmark branding, glowing medical graphics, and a "US FDA APPROVED" label, against a blurred pharmaceutical manufacturing background.

A modern fluticasone inhaler with Glenmark branding, glowing medical graphics, and a "US FDA APPROVED" label, against a blurred pharmaceutical manufacturing background.

Glenmark’s Fluticasone Inhaler Approved by US FDA

sivam March 4, 2026

Glenmark Pharmaceuticals secures US FDA approval for its fluticasone propionate inhaler. This strategic move strengthens their respiratory...

ZYOG1: The Oral GLP-1 That India Couldn’t Launch Conceptual image showing a modern GLP-1 device and a DNA helix transitioning to a dilapidated factory with 'INDIA' written on it.